Dermata Therapeutics Stock (NASDAQ:DRMA), Quotes and News Summary

Q: What sector and industry does Dermata Therapeutics (DRMA) operate in?

Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Dermata Therapeutics Stock (NASDAQ: DRMA) stock price, news, charts, stock research, profile.

Open	$0.334
Close	$0.359
Volume / Avg.	196.315K / 117.387K
Day Range	0.325 - 0.411
52 Wk Range	0.232 - 3.680
Market Cap	$2.237M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	45
Short Interest	1.21%
Days to Cover	1

Recent News

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Applied Therapeutics, Inc.

Avi Kapoor

Dow Turns Lower; ISM Services PMI Falls In December

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 70 points on Friday. The Dow traded down 0.19% to 37,369.52 while the NASDAQ rose 0.16% to 14,533.16. The S&P 500 also rose, gaining, 0.12% to 4,694.09.

Avi Kapoor

Why Is Aesthetic Skin Conditions-Focused Dermata Therapeutics Stock Trading Higher Today?

Dermata Therapeutics Inc (NASDAQ: DRMA) stock was trading higher Friday after the company announced the issuance of a new patent in Japan for its

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dermata Therapeutics (DRMA) stock?

You can purchase shares of Dermata Therapeutics (NASDAQ: DRMA) through any online brokerage.

View our list of the best stock brokerages.

Who are Dermata Therapeutics's (DRMA) competitors?

Other companies in Dermata Therapeutics’s space includes: NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX), Qualigen Therapeutics (NASDAQ:QLGN) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).

What is the target price for Dermata Therapeutics (DRMA) stock?

The latest price target for Dermata Therapeutics (NASDAQ: DRMA) was reported by Maxim Group on Thursday, March 23, 2023. The analyst firm set a price target for 4.00 expecting DRMA to rise to within 12 months (a possible 1091.19% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Dermata Therapeutics (DRMA)?

The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $0.3358 last updated May 10, 2024 at 5:23 PM EDT.

Does Dermata Therapeutics (DRMA) pay a dividend?

There are no upcoming dividends for Dermata Therapeutics.

When is Dermata Therapeutics (NASDAQ:DRMA) reporting earnings?

Dermata Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.

Is Dermata Therapeutics (DRMA) going to split?

There is no upcoming split for Dermata Therapeutics.

What sector and industry does Dermata Therapeutics (DRMA) operate in?

Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-